medigraphic.com

2010, Number 2

<< Back Next >>

Enf Infec Microbiol 2010; 30 (2)

Bordetella pertussis infection in infants. Prospects through maternal vaccination with DTPa vaccine

Vidal VP, Reyna FJ, López CVR, Gómez ACM, Sánchez HE, Hernández PJ

Language: Spanish
References: 23
Page: 59-62
PDF size: 68.40 Kb.


ABSTRACT

The incidence of complications by pertussis diseases has steadily increases in the last times. This is especially true for infants minors of a year of age.
There is substantial indirect evidence that maternal antibodies protect neonates from pertussis-related death. The immunization with pertussis in some studies has demonstrated by means of cordocentesis the increase in fetal levels of IgG during the second and third trimesters of the pregnancy. DPTa is a recently authorized vaccine in the pregnancy, but limited data suggesting that high maternal pertussis antibodies interfere with immune responses in infants given whole cell pertussis vaccines. Apparently, no suppression has been shown for acelular pertussis antigens. Some studies that clarify this topic might be necessaries.


REFERENCES

  1. 1.WHO. “Challenges in global immunization and the glo-bal immunization vision and strategy 2006-2015”. Wkly Epidemiol Rec 2006; 81: 190.

  2. 2.Hurtado OC, Matías JNA. “Historia de la vacunación en México”. Vac Hoy Rev Mex Puer Pediatr 2005; 13: 47-52.

  3. 3.Ulloa GR, Ávila AML. “Pertussis in Latin America: Current situation and future vaccination challenges”. Expert Rev Vaccines 2008; 7: 1569-1580.

  4. 4.“Tosferina brote: Alerta epidemiológica”, en: http:// elbiruniblogspotcom.blogspot.com/2009/03/tosferina-en-nuevo-leon-mexico.html. 30 de marzo de 2009.

  5. 5.UM Médico. “Alertan en Sonora sobre brote de tosferi-na en estados fronterizos”, en http://www.ansa.it/ansa-latina/notizie/notiziari/mexico/20090330210134851997. html. 30 de marzo de 2009.

  6. 6.Akinsanya-Beysolow I, Wolfe CS. “Update: Vaccines for women, adolescence through adulthood”. J Womens Health 2009; 18: 1101-1108.

  7. 7.Dylag AM, Shah SI. “Administration of tetanus, diph-theria, and acellular pertussis vaccine to parents of high-risk infants in the neonatal intensive care unit”. Pediatrics 2008; 122: e550-e555.

  8. 8.Schellekens J, Heinz C, Gardner P. “Pertussis sources of infection and routes of transmission in the vaccination era”. Pediatr Infect Dis J 2005; 24: S19-S24.

  9. 9.Navarrete NS, González RM, Ruiz MC, Casasola FJ. “Estudio epidemiológico de un brote de tosferina en Rincón Grande, Veracruz”. Boletín Médico del Hospital Infantil de México 1990; 47(5): 304-312.

  10. 10.Capuchino MY, Salazar ML, Cárdenas RC. “Perfil clínico epidemiológico de la tosferina en Jalisco en el periodo comprendido entre enero del año 2004 a septiembre del 2005”, en http://docs.google.com/gview?a=v&q= cache:gIBJmdlfrFcJ:www.pediatriajal.org.mx/down-loads/tosfe_jalisco.pdf+brote+de+tosferina+en+jali sco&hl=es&gl=mx. 24 marzo de 2009.

  11. Tomé SP, Torres ALP, Romero QG, Guiscafré GH. “Bor-detella pertussis in adolescents students in Mexico City”. Rev Saúde Pública 2008; 42(4): 679-683.

  12. MMWR. “Preventing tetanus, diphtheria, and pertussis among adults: Use of tetanus toxoid, reduced diphthe-ria toxoid and acellular pertussis vaccine recommenda-tions of the Advisory Committee on Immunization Prac-tices (ACIP) and recommendation of ACIP”. PubMed 2006; 55(17): 1-44.

  13. McIntyre P, Wood N. “Pertussis in early infancy: Disease burden and preventive strategies”. Curr Opin Infect Dis 2009; 22: 215-223.

  14. Gerbie MV, Tan TQ. “Pertussis disease in new mothers: Effect on young infants and strategies for prevention”. Obstet Gynecol 2009; 113(2, pt. 1): 399-401.

  15. Gall S. “Vaccines for pertussis and influenza: Recom-mendations for use in pregnancy”. Clinic Obstetric and Gynec 2008; 51(3): 486-497.

  16. Singh M. “Whooping cough”. Chest 2006; 130: 1547-1550.

  17. Healy CM, Baker CJ. “Prospects for prevention of child-hood infections by maternal immunization”. Current Opinion in Infectious Diseases 2006; 19: 271-276.

  18. Pizzica A, Dunlop AL, Coonrod DV, Jack BW, Boggess KA, Long R, Conry JA, Cox SN, Cefalo R, Hunter KD. “The clinical content of preconception care: Immuni-zations as part of preconception care”. Am J Obstet Gynecol 2008; 199: S290-S295.

  19. De Voer RM, van der Klis FR, Nooitgedagt JE, Versteegh FG, van Huisseling JC, van Rooijen DM, Sanders EA, Ber-bers GA. “Seroprevalence and placental transportation of maternal antibodies specific for Neisseria meningitidis serogroup C, Haemophilus influenzae type B, diphtheria, tetanus, and pertussis”. Clin Infect Dis 2009; 49: 58-64.

  20. Plans P, Jansá J, Doshi N, Harrison TG, Plasencia A. “Prevalence of pertussis antibodies in umbilical cord blood samples in Catalonia, Spain”. Pediatr Infect Dis J 2008; 27: 1023-1025.

  21. Saffar MJ, Khalilian AR, Ajami A, Saffar H, Qaheri A. “Seroimmunity to diphtheria and tetanus among moth-er-infant pairs: The role of maternal immunity on infant immune response to diphtheria-tetanus vaccination”. Swiss Med Wkly 2008; 138: 256-260.

  22. Power ML, Leddy MA, Anderson BL, Gall SA, Gonik B, Schulkin J. “Obstetrician-gynecologists’ practices and perceived knowl-edge regarding immunization”. Am J Prev Med 2009; 37: 231-234.

  23. Gall SA. “Maternal immunization to protect the mother and neonate”. Expert Rev Vaccines 2005; 4: 813-818.




2020     |     www.medigraphic.com